Camlin Fine Sciences Receives Tax Order for ₹48.59 Lakh Demand
Camlin Fine Sciences received a tax order demanding ₹48.59 lakh for ineligible ITC, plus interest and a 50% penalty. The order relates to FY18-19 and FY19-20. The company believes there's no material impact and plans to appeal.
The company explicitly stated that there is no material impact on its financial, operational, or other activities. The amount demanded is also relatively small compared to the company's overall financials, and the intention to appeal further reduces the immediate impact.
The company has received a tax demand order, which is a negative development. However, the company has stated that there is no material impact on its financials and operations and it plans to appeal the order, which mitigates the immediate negative sentiment.
Camlin Fine Sciences Limited has received an Order in Original from the Assistant Commissioner, Office of the Asst./Dy. Commissioner of (CGST & Central Excise), Division -IV, Palghar Commissionerate. The order pertains to a demand for ineligible Input Tax Credit (ITC) amounting to ₹48,58,669 (CGST ₹22,61,630, SGST ₹22,61,630, IGST ₹3,35,409) under Section 74(9) of the CGST Act, 2017, along with corresponding MGST and IGST Acts.
The order also includes applicable interest under Section 50(1) of the CGST Act and a 50% penalty under Section 122(2)(b) of the CGST Act. The alleged violation relates to the short or no reversal of ITC for exempted, nil-rated, or non-GST supplies for the financial years 2018-19 and 2019-20, as reflected in GSTR-3B returns compared to GSTR-9.
The company received this order on December 30, 2025. Camlin Fine Sciences has stated that there is no material impact on its financial, operational, or other activities due to this intimation. The company has examined the order and is in the process of filing an appeal against it.
What to do with a filing like this
Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.